Published in Arthritis Rheum on January 15, 2009
Hand, hip and knee osteoarthritis in a Norwegian population-based study--the MUST protocol. BMC Musculoskelet Disord (2013) 0.88
Simple Scoring System and Artificial Neural Network for Knee Osteoarthritis Risk Prediction: A Cross-Sectional Study. PLoS One (2016) 0.75
Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) (2000) 22.00
EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis (2003) 7.95
Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med (2001) 5.10
EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2004) 4.94
EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis (2000) 4.37
Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Atrial Septal Aneurysm. Stroke (2002) 2.96
Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Ann Rheum Dis (2007) 2.75
Sites of ectopic pregnancy: a 10 year population-based study of 1800 cases. Hum Reprod (2002) 2.63
HTLV-I/II antibodies in French blood donors. Lancet (1990) 2.54
Erdheim-Chester disease: typical radiological bone features for a rare xanthogranulomatosis. Ann Rheum Dis (2002) 2.51
EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees. Ann Rheum Dis (2004) 2.48
Safety of anti-TNF-alpha therapy in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic hepatitis. Rheumatology (Oxford) (2006) 2.43
Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy. Rheumatology (Oxford) (2006) 2.41
Reliability of tuberculin skin test measurement. Ann Intern Med (1997) 2.35
Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of human immunodeficiency virus type 1. J Clin Microbiol (1999) 2.30
Management of osteoarthritis (OA) with an unsupervised home based exercise programme and/or patient administered assessment tools. A cluster randomised controlled trial with a 2x2 factorial design. Ann Rheum Dis (2004) 2.29
Factors determining inpatient satisfaction with care. Soc Sci Med (2002) 2.29
Stenosis of the lumbar spinal canal in vertebral ankylosing hyperostosis. Spine (Phila Pa 1976) (1992) 2.07
Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum (2009) 2.03
Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries. Ann Rheum Dis (2002) 2.02
The value of utility: assumptions underlying preferences and quality adjusted life years. J Rheumatol (1999) 2.01
Management of nontuberculous infectious discitis. treatments used in 110 patients admitted to 12 teaching hospitals in France. Joint Bone Spine (2001) 1.98
Cross-cultural adaptation and validation of health status measures. Scand J Rheumatol (1995) 1.93
Methodological approaches to shortening composite measurement scales. J Clin Epidemiol (1997) 1.85
Early and late seizures after cryptogenic ischemic stroke in young adults. Neurology (2003) 1.79
Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy. Circulation (1999) 1.78
Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections. Pediatr Infect Dis J (1999) 1.75
Natural history of multiple sclerosis in a population-based cohort. Eur J Neurol (2008) 1.73
Compliance to drug treatment of patients with rheumatoid arthritis: a 3 year longitudinal study. J Rheumatol (1999) 1.70
Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer. Int J Radiat Oncol Biol Phys (1998) 1.70
Detection of cases of inflammatory rheumatic disorders: performance of a telephone questionnaire designed for use by patient interviewers. Ann Rheum Dis (2003) 1.69
Fertility following radical, conservative-surgical or medical treatment for tubal pregnancy: a population-based study. BJOG (2000) 1.68
Radiological progression of hip osteoarthritis: definition, risk factors and correlations with clinical status. Ann Rheum Dis (1996) 1.64
Occupational exposure to blood: search for a relation between personality and behavior. Infect Control Hosp Epidemiol (2000) 1.62
Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry. Ann Rheum Dis (2010) 1.59
Effects of joint lavage and steroid injection in patients with osteoarthritis of the knee: results of a multicenter, randomized, controlled trial. Arthritis Rheum (1999) 1.57
Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse. J Rheumatol (1996) 1.56
Controlled ovarian hyperstimulation as a risk factor for ectopic pregnancy. Obstet Gynecol (1991) 1.56
Bias and precision in visual analogue scales: a randomized controlled trial. Am J Epidemiol (1999) 1.56
Neurological complications of varicella-zoster virus infection in adults with human immunodeficiency virus infection. Scand J Infect Dis (2000) 1.55
Segregation analysis and variance components analysis of bone mineral density in healthy families. J Bone Miner Res (1995) 1.55
Prevalence of rheumatoid arthritis and spondyloarthropathy in Brittany, France. Société de Rhumatologie de l'Ouest. J Rheumatol (1999) 1.53
Phenotypic diversity is not determined by independent genetic factors in familial spondylarthropathy. Arthritis Rheum (2001) 1.52
The familial form of spondylarthropathy: a clinical study of 115 multiplex families. Groupe Français d'Etude Génétique des Spondylarthropathies. Arthritis Rheum (2000) 1.51
Delayed methotrexate pneumonitis in rheumatoid arthritis. J Rheumatol (1991) 1.50
Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol (1998) 1.48
Eligibility of rheumatoid arthritis patients for anti-TNF-alpha therapy according to the 2005 recommendations of the French and British Societies for Rheumatology. Rheumatology (Oxford) (2008) 1.47
Use of spa therapy to improve the quality of life of chronic low back pain patients. Med Care (1998) 1.42
[Tuberculous rheumatism. Apropos of a case]. Rev Rhum Ed Fr (1993) 1.39
Increased albuminuria in 4-year-old preterm-born children with normal height. J Pediatr (2012) 1.39
Chromosomal abnormalities and ectopic pregnancy? New directions for aetiological research. Hum Reprod (1996) 1.39
Lactose intolerance and osteoporosis in men. Rev Rhum Engl Ed (1995) 1.39
The Groningen Activity Restriction Scale for measuring disability: its utility in international comparisons. Am J Public Health (1994) 1.38
Fluoroquinolone induced arthralgia and magnetic resonance imaging. J Rheumatol (1996) 1.38
Radiographic scoring methods as outcome measures in rheumatoid arthritis: properties and advantages. Ann Rheum Dis (2001) 1.37
The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case-crossover study. Thorax (2008) 1.35
Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage. Stroke (1999) 1.34
Fatigue in multiple sclerosis is related to disability, depression and quality of life. J Neurol Sci (2006) 1.32
Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries. Ann Rheum Dis (2003) 1.31
Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. Cancer Res (2001) 1.30
Conservative treatment by irradiation of epidermoid cancers of the anal canal: prognostic factors of tumoral control and complications. Int J Radiat Oncol Biol Phys (1997) 1.30
Spheroids in radiobiology and photodynamic therapy. Crit Rev Oncol Hematol (2001) 1.29
Prevalence of spondyloarthropathies in France: 2001. Ann Rheum Dis (2005) 1.27
The AIMS2-SF: a short form of the Arthritis Impact Measurement Scales 2. French Quality of Life in Rheumatology Group. Arthritis Rheum (1997) 1.26
Cancer in systemic sclerosis. Arthritis Rheum (1993) 1.24
A comparison of agreement and sensitivity to change between AIMS2 and a short form of AIMS2 (AIMS2-SF) in more than 1,000 rheumatoid arthritis patients. J Rheumatol (2000) 1.24
In vitro infection of adult normal human hepatocytes in primary culture by hepatitis C virus. J Gen Virol (1998) 1.23
Procalcitonin in children admitted to hospital with community acquired pneumonia. Arch Dis Child (2001) 1.23
Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature. Clin Exp Rheumatol (2008) 1.22
Self-administered questionnaire compared with interview to assess past-year physical activity. Med Sci Sports Exerc (2000) 1.20
Efficacy studies on a canarypox-rabies recombinant virus. Vaccine (1991) 1.20
Is camptocormia a primary muscular disease? Spine (Phila Pa 1976) (1995) 1.19
Prevalence of impairments, disabilities, handicaps and quality of life in the general population: a review of recent literature. Bull World Health Organ (2001) 1.19
MTT assays allow quick and reliable measurement of the response of human tumour cells to photodynamic therapy. Eur J Cancer (1992) 1.18
Nonspecific effects in longitudinal studies: impact on quality of life measures. J Clin Epidemiol (1996) 1.17
Requirement for total hip arthroplasty: an outcome measure of hip osteoarthritis? J Rheumatol (1999) 1.17
Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the 'Orencia and Rheumatoid Arthritis' registry. Ann Rheum Dis (2012) 1.16
Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. The GEMHEP. J Viral Hepat (1999) 1.16
Use of the EQ-5D among patients suffering from dementia. J Clin Epidemiol (2003) 1.15
Insufficiency fracture of the sacrum revealing a pregnancy associated osteoporosis. First case report. Ann Rheum Dis (1997) 1.15
Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort. Ann Rheum Dis (2011) 1.15
[Etanercept--infliximab switch in rheumatoid arthritis 14 out of 131 patients treated with anti TNFalpha]. Presse Med (2002) 1.14
Comparing non-enhanced and enhanced sequences in the assessment of effusion and synovitis in knee OA: associations with clinical, macroscopic and microscopic features. Osteoarthritis Cartilage (2011) 1.14
Impact of musculoskeletal disorders on quality of life: an inception cohort study. Ann Rheum Dis (2004) 1.13
Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study. Rheumatology (Oxford) (2002) 1.12
Prevalence of rheumatoid arthritis in France: 2001. Ann Rheum Dis (2005) 1.12
Influence of muscle strength and body weight and composition on regional bone mineral density in healthy women aged 60 years and over. Gerontology (2001) 1.11
Cross-cultural adaptation and validation of the French version of the Knee injury and Osteoarthritis Outcome Score (KOOS) in knee osteoarthritis patients. Osteoarthritis Cartilage (2007) 1.11